Why the study?
Does the novel microRNA hsa-miR-Chr8:96 distinguish patients with acute myocarditis from those with myocardial infarction?
Does the novel microRNA hsa-miR-Chr8:96 distinguish patients with acute myocarditis from those with myocardial infarction?
The novel microRNA hsa-miR-Chr8:96 may serve as a circulating biomarker to differentiate acute myocarditis from myocardial infarction.
Requires human validation before any diagnostic consideration; leaves open its role as a myocarditis biomarker.
After identifying a novel microRNA in mice and humans with myocarditis, we found that the human homologue (hsa-miR-Chr8:96) could be used to distinguish patients with myocarditis from those with myocardial infarction. (Funded by the Spanish Ministry of Science and Innovation and others.).
No takes yet. Share an insight, caveat, or question.
Blanco-Domínguez et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: